Very interesting indeed — although not actually a new discovery, as I notice there are studies on the benefits of
famotidine for schizophrenia that date back to the early 1990s.
However, this info on famotidine is certainly new to me, and I am grateful that you posted it, because in addition to having ME/CFS, I also have significant
emotional flatness (
blunted affect) and
anhedonia (anhedonia is the inability to feel pleasure or reward from activities), and both of these conditions are part of the negative symptoms of schizophrenia, which famotidine apparently treats.
The full set of negative symptoms of schizophrenia are: emotional flatness, anhedonia, poverty of speech, lack of desire to form relationships, and lack of motivation.
This 1994 study found that famotidine 20 mg twice daily improves the negative (deficit) symptoms of schizophrenia. The study said that after two or three weeks on famotidine, all schizophrenia patients showed marked improvement in their motivation, and there was an improvement in their symptoms of social withdrawal, low social drive, and poverty of speech (the patients became more sociable, more verbal and more active on famotidine).
So maybe famotidine will help my anhedonia and emotional flatness symptoms. I am definitely going to try it.
There does seem to be a bit of a difference in dose between this 1994 study, and the new 2013 study by Prof. Jesper Ekelund that you cited, Natasa: the 2013 study used a very high dose of 200 mg of famotidine a day.
Interestingly,
this 1993 study on famotidine for schizophrenia (they also used 20 mg twice daily) says that other H2 receptor antagonist drugs that penetrate the blood-brain barrier better than famotidine should be tested for schizophrenia as well.
Cimetidine (Tagamet)
Apparently the H2 receptor antagonist
cimetidine (Tagamet) crosses the blood-brain barrier more easily than famotidine, so perhaps cimetidine might also work for the negative symptoms of schizophrenia? (But famotidine is 20 to 50 times more potent than cimetidine, so this may make up for the lower blood-brain barrier penetration of famotidine).
Cimetidine is one of the drugs known to be beneficial for ME/CFS.
Cimetidine is antiviral for both
herpes simplex virus and
herpes varicella zoster virus. Ref:
here.
Cimetidine treats
interstitial cystitis, a common comorbid condition in ME/CFS.
Cimetidine boosts immune function by reducing T-suppressor cells (T-regs).
Searching this forum, it seems people here take cimetidine for ME/CFS in doses ranging from 100 to 800 mg a day.
For treating herpes zoster virus, the cimetidine dose is 200 mg three times daily, and 400 mg before bed. Ref:
here.
For interstitial cystitis, the cimetidine dose is 300 mg twice a day. Ref:
here.
For mononucleosis, Dr Jay Goldstein uses cimetidine 300 mg three times a day, for 5 days. Ref:
here.
Cimetidine can cause testicular damage in rats, but vitamin B12 helps mitigate this damage. Ref:
here.
In Maija Haavisto's ME/CFS book "
Reviving the Broken Marionette" (free abridged version
here) she writes the following about cimetidine (Tagamet) and ranitidine (Zantac) for ME/CFS:
Cimetidine (Tagamet) and ranitidine (Zantac) for CFS
Ranitidine and cimetidine are antagonists of the H2 histamine receptor. Because of this they are often called antihistamines, though their effects are quite different from the antiallergic drugs (which act on the H1 receptor). They are used to reduce the secretion of stomach acid in ulcer prevention and treatment, but have largely been surpassed by the proton pump inhibitors. They may be useful for allergic symptoms in conjunction with H1 antagonists (“normal” antihistamines).
Dr. Jay Goldstein discovered in the 1980s that H2 receptor antagonists can be very effective against infectious mononucleosis. Because at the time CFS/ME was thought to be a form of chronic mononucleosis, he also tried them in CFS/ME patients, often with good results. He believes the effects may result from the cholinergic and NMDA antagonist properties of the drugs. Devin Starlanyl notes these drugs may be useful in fibromyalgia for promoting stage 4 sleep, especially with amitriptyline.
The H2 antagonists have some immunostimulatory properties. They can be used to treat interstitial cystitis and painful bladder disease. There is some evidence H2 antagonists are helpful for weight loss. They have shown some efficacy in reducing the weight gain caused by olanzapine (an antipsychotic). This might apply to other medications that cause weight gain, as well. Additionally they potentiate opioid analgesia.
According to Goldstein H2 antagonists may cause restlessness and overstimulation in patients with CFS/ME and fibromyalgia. Headache is also possible and rarely may be severe. Occasionally H2 antagonists cause allergic reactions. People with SLE may experience lupus flares.
The H2 antagonists may also increase the requirements of folic acid, vitamin B12 and zinc. Cimetidine may interact with phenytoin, carbamazepine, lidocaine, opioids, theophylline and tricyclic antidepressants. Cimetidine and ranitidine are widely available.
Low doses of cimetidine are available over–the–counter in the United States and some other countries. Ranitidine is available without prescription in the United States, the United Kingdom and Australia.